Cyclo Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2011 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Cyclo Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2011 to Q4 2023.
  • Cyclo Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $24.8M, a 7.17% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $24.8M +$1.66M +7.17% Dec 31, 2023 10-K 2024-03-18
Q4 2022 $23.2M +$5.46M +30.9% Dec 31, 2022 10-K 2024-03-18
Q4 2021 $17.7M +$5.52M +45.3% Dec 31, 2021 10-K 2023-03-17
Q4 2020 $12.2M +$3.3M +37.2% Dec 31, 2020 10-K 2022-03-11
Q4 2019 $8.88M +$2.65M +42.4% Dec 31, 2019 10-K 2021-03-12
Q4 2018 $6.24M +$1.58M +33.8% Dec 31, 2018 10-K 2020-03-30
Q4 2017 $4.66M +$1.04M +28.9% Dec 31, 2017 10-K 2019-03-15
Q4 2016 $3.62M +$2.16M +149% Dec 31, 2016 10-K 2018-04-16
Q4 2015 $1.45M +$1.24M +591% Dec 31, 2015 10-K 2017-03-17
Q4 2014 $210K +$203K Dec 31, 2014 10-K 2016-03-30
Q4 2013 $7K* -$14K Dec 31, 2013 10-K 2015-03-27
Q4 2012 $21K -$76K -78.4% Dec 31, 2012 10-K 2014-03-04
Q4 2011 $97K Dec 31, 2011 10-K 2013-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.